Analytical Methodologies to Detect N-Nitrosamine Impurities in Active Pharmaceutical Ingredients, Drug Products and Other Matrices

活性成分 药品 化学 药物 色谱法 亚硝胺 生化工程 有机化学 组合化学 药理学 医学 致癌物 工程类
作者
Krishna Moorthy Manchuri,Mahammad Ali Shaik,G. V. REDDY,Naziya Sultana,Sreenivasarao Gogineni
出处
期刊:Chemical Research in Toxicology [American Chemical Society]
标识
DOI:10.1021/acs.chemrestox.4c00234
摘要

Since 2018, N-nitrosamine impurities have become a widespread concern in the global regulatory landscape of pharmaceutical products. This concern arises due to their potential for contamination, toxicity, carcinogenicity, and mutagenicity and their presence in many active pharmaceutical ingredients, drug products, and other matrices. N-Nitrosamine impurities in humans can lead to severe chemical toxicity effects. These include carcinogenic effects, metabolic disruptions, reproductive harm, liver diseases, obesity, DNA damage, cell death, chromosomal alterations, birth defects, and pregnancy loss. They are particularly known to cause cancer (tumors) in various organs and tissues such as the liver, lungs, nasal cavity, esophagus, pancreas, stomach, urinary bladder, colon, kidneys, and central nervous system. Additionally, N-nitrosamine impurities may contribute to the development of Alzheimer's and Parkinson's diseases and type-2 diabetes. Therefore, it is very important to control or avoid them by enhancing effective analytical methodologies using cutting-edge analytical techniques such as LC-MS, GC-MS, CE-MS, SFC, etc. Moreover, these analytical methods need to be sensitive and selective with suitable precision and accuracy, so that the actual amounts of N-nitrosamine impurities can be detected and quantified appropriately in drugs. Regulatory agencies such as the US FDA, EMA, ICH, WHO, etc. need to focus more on the hazards of N-nitrosamine impurities by providing guidance and regular updates to drug manufacturers and applicants. Similarly, drug manufacturers should be more vigilant to avoid nitrosating agents and secondary amines during the manufacturing processes. Numerous review articles have been published recently by various researchers, focusing on N-nitrosamine impurities found in previously notified products, including sartans, metformin, and ranitidine. These impurities have also been detected in a wide range of other products. Consequently, this review aims to concentrate on products recently reported to contain N-nitrosamine impurities. These products include rifampicin, champix, famotidine, nizatidine, atorvastatin, bumetanide, itraconazole, diovan, enalapril, propranolol, lisinopril, duloxetine, rivaroxaban, pioglitazones, glifizones, cilostazol, and sunitinib.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
脑洞疼应助格物致知采纳,获得10
刚刚
领导范儿应助魏猛采纳,获得10
刚刚
1秒前
2秒前
3秒前
3秒前
称心文博完成签到,获得积分10
5秒前
6秒前
6秒前
superluckc发布了新的文献求助10
7秒前
8秒前
柚子发布了新的文献求助10
9秒前
撒大苏打完成签到,获得积分10
10秒前
爱喝水完成签到,获得积分10
11秒前
称心文博发布了新的文献求助10
11秒前
小巧凝丹完成签到,获得积分10
11秒前
LPPP发布了新的文献求助10
12秒前
12秒前
13秒前
superluckc完成签到,获得积分20
15秒前
慕青应助kaka091采纳,获得10
15秒前
华仔应助称心文博采纳,获得30
16秒前
万松辉完成签到,获得积分10
16秒前
魏猛发布了新的文献求助10
17秒前
张小咩咩完成签到 ,获得积分10
17秒前
18秒前
乐乐应助superluckc采纳,获得10
19秒前
坚强难摧发布了新的文献求助10
20秒前
丘比特应助htmy采纳,获得10
21秒前
可爱的函函应助LShi采纳,获得10
21秒前
Ashy完成签到 ,获得积分10
23秒前
格物致知发布了新的文献求助10
23秒前
24秒前
柚子完成签到,获得积分10
25秒前
Ashy关注了科研通微信公众号
27秒前
kaka091发布了新的文献求助10
29秒前
30秒前
情怀应助平淡的寄风采纳,获得10
30秒前
万能图书馆应助坚强难摧采纳,获得10
31秒前
31秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Foreign Policy of the French Second Empire: A Bibliography 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
XAFS for Everyone 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3145219
求助须知:如何正确求助?哪些是违规求助? 2796603
关于积分的说明 7820639
捐赠科研通 2452983
什么是DOI,文献DOI怎么找? 1305309
科研通“疑难数据库(出版商)”最低求助积分说明 627466
版权声明 601464